XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 25.22

-5.0%

Dec 12 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert S. who wrote (8237)	1/7/1999 9:21:00 PM
From: Robert K.	Read Replies (3) of 17367

I find that attempt at valuation interesting. One of your more interesting notes in fact. So let me get this straight. If xoma had 30% market penetration AND got approvals for >meningococcemia >abdominal >cystic fibrosis >liver indications >Hem. Trauma >Hu1124 THEN, it would only be worth under $7.00 Summary> >soooo, that means that if it works in all those indications that you would NOT buy it over $8.00 per share. Right. VBG. Besides, you are ignoring ALL those other minor indications like antibiotic synergy vs resistance (a small market) Hey, how about mycoprex? Lets see a oral, fungiCIDAL, that is low toxicity and Synergizes fluconazle(vs AIDS,Cancer etc). THAT cant be worth much either I guess. Neither is CANCER I guess. To name just a few. So In summary you are saying > DONT pay over $7.00 for the stock until it gets more approvals then in those indications you listed. Right. I think I get it> VBG. Actually, its your opinion, and you have a right to it. I just dont have to agree with it.. All IMO and a VBG.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next